pharma · COVID19 · COVID-19 Pandemic
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group is a pharma organization headquartered in CN. Primary therapeutic focus areas include COVID19, COVID-19 Pandemic. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent re
CN HQ
1985 Founded
656 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Founded
- 1985
- Employees
- 656
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Recombinant SARS-CoV-2 fusion protein vaccine (V-01)
Phase 3 · mab · COVID-19 Pandemic
Recombinant SARS-CoV-2 fusion protein vaccine (V-01) for COVID-19 Pandemic is a Phase 3 program (mab) at Livzon Pharmaceutical Group with 1 ClinicalTrials.gov record(s).
Internal code TG2101V01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Livzon Pharmaceutical Group
- Phase
- Phase 3
- Modality
- mab
- Indication
- COVID-19 Pandemic
- Status
- active
- Trials
- 1